Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 3
2006 1
2007 3
2008 6
2009 5
2010 11
2011 13
2012 11
2013 10
2014 17
2015 21
2016 13
2017 12
2018 8
2019 8
2020 7
2021 4
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
Lee NY, Hum M, Amali AA, Lim WK, Wong M, Myint MK, Tay RJ, Ong PY, Samol J, Lim CW, Ang P, Tan MH, Lee SC, Lee ASG. Lee NY, et al. Among authors: tan mh. Hum Genomics. 2022 Dec 19;16(1):68. doi: 10.1186/s40246-022-00443-7. Hum Genomics. 2022. PMID: 36536425 Free PMC article. No abstract available.
A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples.
Ng CC, Lim S, Lim AH, Md Nasir ND, Zhang J, Rajasegaran V, Lee JY, Kok JST, Thike AA, Lim JX, Weng R, Yee S, Choudhury Y, Chan JY, Tan PH, Tan MH, Teh BT. Ng CC, et al. Among authors: tan mh. Front Mol Biosci. 2022 Sep 21;9:963243. doi: 10.3389/fmolb.2022.963243. eCollection 2022. Front Mol Biosci. 2022. PMID: 36213130 Free PMC article.
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.
Ravi P, Ravi A, Riaz IB, Freeman D, Curran C, Mantia C, McGregor BA, Kilbridge KL, Pan CX, Pek M, Choudhury Y, Tan MH, Sonpavde GP. Ravi P, et al. Among authors: tan mh. Oncologist. 2022 May 6;27(5):e406-e409. doi: 10.1093/oncolo/oyac037. Oncologist. 2022. PMID: 35294031 Free PMC article.
141 results